Objectives: This study reports on the safety of the complementary and alternative medicine (CAM) practice of cupping in a patient undergoing concomitant therapy with bevacizumab for advanced non-small-cell lung cancer (NSCLC), and raises awareness of the need for improved communication between CAM practitioners and oncologists during the care of patients with cancer. The practice of cupping generates local hyperemia, disrupts superficial vasculature in the dermis, and leads to cutaneous lesions including circular erythema, edema, and subsequently ecchymosis. There are no data on the safety of cupping in patients being treated with bevacizumab.
Design: This is a single-institution case report.
Settings/location: The setting for this study was a tertiary-care academic medical center.
Conclusions: A patient with advanced NSCLC received four cycles of carboplatin AUC 6, paclitaxel 200 mg/m(2), and bevacizumab 15 mg/kg, and was continued on every-3-week maintenance bevacizumab 15 mg/kg. The patient underwent glass dry cupping during cycle six of maintenance bevacizumab treatment without overt cutaneous adverse events or bleeding. The patient did not realize he should have communicated his cupping plans or recent bevacizumab treatment with his providers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/acm.2011.0791 | DOI Listing |
Front Med (Lausanne)
December 2024
School of Acupuncture-Moxibustion and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background: Neurodermatitis is a chronic skin condition characterized by intense itching and skin thickening due to neurological dysfunction. Its persistent nature poses a challenge to effective treatment, significantly impacting patients' quality of life. Wet cupping therapy is increasingly being used in clinics to manage neurodermatitis, so it is imperative to assess the evidence regarding its effectiveness and safety.
View Article and Find Full Text PDFBackground: Cupping therapy (CT) on acupoint CV8 Shenque is a potential treatment of urticaria. This review will analyze the efficacy and safety of CT on CV8 Shenque.
Methods: Randomized controlled trials (RCTs) comparing CT on CV8 Shenque with other treatments were retrieved from 14 worldwide databases from their inception to June 2024.
Front Neurol
December 2024
Research Department, Swiss TCM University, Bad Zurzach, Switzerland.
Front Neurol
December 2024
Department of Acupuncture, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Explore (NY)
January 2025
Department of Dermatology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, Sichuan province, China. Electronic address:
Introduction: Psoriasis is a chronic inflammatory skin disease that can present in various phenotypes, with the most common form being plaque psoriasis. Currently, no type of psoriasis can be cured, and existing treatment options are associated with certain safety concerns. In recent years, traditional Chinese medicine has achieved great results in treating psoriasis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!